 | • レポートコード：GIR201113879 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、臨床次世代シーケンシングの世界市場を調査対象にし、臨床次世代シーケンシングの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ターゲットシーケンス、エクソームシーケンス、その他）、用途別分析（病院及び診療所、バイオ製薬会社、学術及び研究機関、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Thermo Fisher Scientific、Beckman Coulter、PerkinElmer、Illumina、Qiagen、GATC Biotech ・企業別売上、市場シェア ・臨床次世代シーケンシングの地域別市場分析 ・臨床次世代シーケンシングの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・臨床次世代シーケンシングのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・臨床次世代シーケンシングのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・臨床次世代シーケンシングの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・臨床次世代シーケンシングの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・臨床次世代シーケンシングの種類別市場規模2015-2020：ターゲットシーケンス、エクソームシーケンス、その他 ・臨床次世代シーケンシングの用途別市場規模2015-2020：病院及び診療所、バイオ製薬会社、学術及び研究機関、その他 ・臨床次世代シーケンシングの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Clinical Next-Generation Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Clinical Next-Generation Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Clinical Next-Generation Sequencing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Clinical Next-Generation Sequencing market has been segmented into:
Targeted Sequencing
Exome Sequencing
Others
By Application, Clinical Next-Generation Sequencing has been segmented into:
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Clinical Next-Generation Sequencing market presented in the report. This section sheds light on the sales growth of different regional and country-level Clinical Next-Generation Sequencing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Clinical Next-Generation Sequencing market.
The report offers in-depth assessment of the growth and other aspects of the Clinical Next-Generation Sequencing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Clinical Next-Generation Sequencing Market Share Analysis
Clinical Next-Generation Sequencing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Clinical Next-Generation Sequencing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Clinical Next-Generation Sequencing sales, revenue and market share for each player covered in this report.
The major players covered in Clinical Next-Generation Sequencing are:
Thermo Fisher Scientific
Beckman Coulter
PerkinElmer
Illumina
Qiagen
GATC Biotech
1 Clinical Next-Generation Sequencing Market Overview
1.1 Product Overview and Scope of Clinical Next-Generation Sequencing
1.2 Classification of Clinical Next-Generation Sequencing by Type
1.2.1 Global Clinical Next-Generation Sequencing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Type in 2019
1.2.3 Targeted Sequencing
1.2.4 Exome Sequencing
1.2.5 Others
1.3 Global Clinical Next-Generation Sequencing Market by Application
1.3.1 Overview: Global Clinical Next-Generation Sequencing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Global Clinical Next-Generation Sequencing Market by Regions
1.4.1 Global Clinical Next-Generation Sequencing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Clinical Next-Generation Sequencing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Clinical Next-Generation Sequencing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Clinical Next-Generation Sequencing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Clinical Next-Generation Sequencing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Clinical Next-Generation Sequencing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Clinical Next-Generation Sequencing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Beckman Coulter SWOT Analysis
2.2.4 Beckman Coulter Product and Services
2.2.5 Beckman Coulter Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.3 PerkinElmer
2.3.1 PerkinElmer Details
2.3.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 PerkinElmer SWOT Analysis
2.3.4 PerkinElmer Product and Services
2.3.5 PerkinElmer Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Illumina SWOT Analysis
2.4.4 Illumina Product and Services
2.4.5 Illumina Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Qiagen
2.5.1 Qiagen Details
2.5.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Qiagen SWOT Analysis
2.5.4 Qiagen Product and Services
2.5.5 Qiagen Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.6 GATC Biotech
2.6.1 GATC Biotech Details
2.6.2 GATC Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GATC Biotech SWOT Analysis
2.6.4 GATC Biotech Product and Services
2.6.5 GATC Biotech Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Clinical Next-Generation Sequencing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Clinical Next-Generation Sequencing Players Market Share
3.2.2 Top 10 Clinical Next-Generation Sequencing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Clinical Next-Generation Sequencing Revenue and Market Share by Regions
4.2 North America Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
4.3 Europe Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
4.5 South America Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
5 North America Clinical Next-Generation Sequencing Revenue by Countries
5.1 North America Clinical Next-Generation Sequencing Revenue by Countries (2015-2020)
5.2 USA Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
5.3 Canada Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
5.4 Mexico Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6 Europe Clinical Next-Generation Sequencing Revenue by Countries
6.1 Europe Clinical Next-Generation Sequencing Revenue by Countries (2015-2020)
6.2 Germany Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6.3 UK Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6.4 France Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6.5 Russia Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6.6 Italy Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Countries
7.1 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Countries (2015-2020)
7.2 China Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7.3 Japan Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7.4 Korea Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7.5 India Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
8 South America Clinical Next-Generation Sequencing Revenue by Countries
8.1 South America Clinical Next-Generation Sequencing Revenue by Countries (2015-2020)
8.2 Brazil Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
8.3 Argentina Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Clinical Next-Generation Sequencing by Countries
9.1 Middle East & Africa Clinical Next-Generation Sequencing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
9.3 UAE Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
9.4 Egypt Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
9.5 South Africa Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Clinical Next-Generation Sequencing Revenue and Market Share by Type (2015-2020)
10.2 Global Clinical Next-Generation Sequencing Market Forecast by Type (2019-2024)
10.3 Targeted Sequencing Revenue Growth Rate (2015-2025)
10.4 Exome Sequencing Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Clinical Next-Generation Sequencing Market Segment by Application
11.1 Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2015-2020)
11.2 Clinical Next-Generation Sequencing Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Biopharma Companies Revenue Growth (2015-2020)
11.5 Academic and Research Organizations Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Clinical Next-Generation Sequencing Market Size Forecast (2021-2025)
12.1 Global Clinical Next-Generation Sequencing Market Size Forecast (2021-2025)
12.2 Global Clinical Next-Generation Sequencing Market Forecast by Regions (2021-2025)
12.3 North America Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
12.4 Europe Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
12.6 South America Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Clinical Next-Generation Sequencing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Clinical Next-Generation Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Clinical Next-Generation Sequencing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Clinical Next-Generation Sequencing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Clinical Next-Generation Sequencing Major Business
Table 7. Thermo Fisher Scientific Clinical Next-Generation Sequencing Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Clinical Next-Generation Sequencing Product and Solutions
Table 10. Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Beckman Coulter Corporate Information, Location and Competitors
Table 12. Beckman Coulter Clinical Next-Generation Sequencing Major Business
Table 13. Beckman Coulter Clinical Next-Generation Sequencing Total Revenue (USD Million) (2018-2019)
Table 14. Beckman Coulter SWOT Analysis
Table 15. Beckman Coulter Clinical Next-Generation Sequencing Product and Solutions
Table 16. Beckman Coulter Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. PerkinElmer Corporate Information, Location and Competitors
Table 18. PerkinElmer Clinical Next-Generation Sequencing Major Business
Table 19. PerkinElmer Clinical Next-Generation Sequencing Total Revenue (USD Million) (2017-2018)
Table 20. PerkinElmer SWOT Analysis
Table 21. PerkinElmer Clinical Next-Generation Sequencing Product and Solutions
Table 22. PerkinElmer Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Illumina Corporate Information, Location and Competitors
Table 24. Illumina Clinical Next-Generation Sequencing Major Business
Table 25. Illumina Clinical Next-Generation Sequencing Total Revenue (USD Million) (2017-2018)
Table 26. Illumina SWOT Analysis
Table 27. Illumina Clinical Next-Generation Sequencing Product and Solutions
Table 28. Illumina Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Qiagen Corporate Information, Location and Competitors
Table 30. Qiagen Clinical Next-Generation Sequencing Major Business
Table 31. Qiagen Clinical Next-Generation Sequencing Total Revenue (USD Million) (2017-2018)
Table 32. Qiagen SWOT Analysis
Table 33. Qiagen Clinical Next-Generation Sequencing Product and Solutions
Table 34. Qiagen Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GATC Biotech Corporate Information, Location and Competitors
Table 36. GATC Biotech Clinical Next-Generation Sequencing Major Business
Table 37. GATC Biotech Clinical Next-Generation Sequencing Total Revenue (USD Million) (2017-2018)
Table 38. GATC Biotech SWOT Analysis
Table 39. GATC Biotech Clinical Next-Generation Sequencing Product and Solutions
Table 40. GATC Biotech Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Clinical Next-Generation Sequencing Revenue (Million USD) by Players (2015-2020)
Table 42. Global Clinical Next-Generation Sequencing Revenue Share by Players (2015-2020)
Table 43. Global Clinical Next-Generation Sequencing Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Clinical Next-Generation Sequencing Revenue Market Share by Regions (2015-2020)
Table 45. North America Clinical Next-Generation Sequencing Revenue by Countries (2015-2020)
Table 46. North America Clinical Next-Generation Sequencing Revenue Market Share by Countries (2015-2020)
Table 47. Europe Clinical Next-Generation Sequencing Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Clinical Next-Generation Sequencing Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Clinical Next-Generation Sequencing Revenue by Countries (2015-2020)
Table 50. South America Clinical Next-Generation Sequencing Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Clinical Next-Generation Sequencing Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Clinical Next-Generation Sequencing Revenue Market Share by Countries (2015-2020)
Table 53. Global Clinical Next-Generation Sequencing Revenue (Million USD) by Type (2015-2020)
Table 54. Global Clinical Next-Generation Sequencing Revenue Share by Type (2015-2020)
Table 55. Global Clinical Next-Generation Sequencing Revenue Forecast by Type (2021-2025)
Table 56. Global Clinical Next-Generation Sequencing Revenue by Application (2015-2020)
Table 57. Global Clinical Next-Generation Sequencing Revenue Share by Application (2015-2020)
Table 58. Global Clinical Next-Generation Sequencing Revenue Forecast by Application (2021-2025)
Table 59. Global Clinical Next-Generation Sequencing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Clinical Next-Generation Sequencing Picture
Figure 2. Global Clinical Next-Generation Sequencing Revenue Market Share by Type in 2019
Figure 3. Targeted Sequencing Picture
Figure 4. Exome Sequencing Picture
Figure 5. Others Picture
Figure 6. Clinical Next-Generation Sequencing Revenue Market Share by Application in 2019
Figure 7. Hospitals and Clinics Picture
Figure 8. Biopharma Companies Picture
Figure 9. Academic and Research Organizations Picture
Figure 10. Others Picture
Figure 11. Global Clinical Next-Generation Sequencing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Clinical Next-Generation Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Clinical Next-Generation Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Clinical Next-Generation Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Clinical Next-Generation Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Clinical Next-Generation Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Clinical Next-Generation Sequencing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Clinical Next-Generation Sequencing Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Clinical Next-Generation Sequencing Revenue Market Share in 2019
Figure 20. Global Top 10 Players Clinical Next-Generation Sequencing Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Clinical Next-Generation Sequencing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Clinical Next-Generation Sequencing Revenue Market Share by Regions (2015-2020)
Figure 24. Global Clinical Next-Generation Sequencing Revenue Market Share by Regions in 2018
Figure 25. North America Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 26. Europe Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 28. South America Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 30. North America Clinical Next-Generation Sequencing Revenue Market Share by Countries (2015-2020)
Figure 31. North America Clinical Next-Generation Sequencing Revenue Market Share by Countries in 2019
Figure 32. USA Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 33. Canada Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 35. Europe Clinical Next-Generation Sequencing Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Clinical Next-Generation Sequencing Revenue Market Share by Countries in 2019
Figure 37. Germany Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 38. UK Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 39. France Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 40. Russia Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 41. Italy Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Clinical Next-Generation Sequencing Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Clinical Next-Generation Sequencing Revenue Market Share by Countries in 2019
Figure 44. China Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 45. Japan Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 46. Korea Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 47. India Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 49. South America Clinical Next-Generation Sequencing Revenue Market Share by Countries (2015-2020)
Figure 50. South America Clinical Next-Generation Sequencing Revenue Market Share by Countries in 2019
Figure 51. Brazil Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Clinical Next-Generation Sequencing Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Clinical Next-Generation Sequencing Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 56. UAE Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Clinical Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
Figure 59. Global Clinical Next-Generation Sequencing Revenue Share by Type (2015-2020)
Figure 60. Global Clinical Next-Generation Sequencing Revenue Share by Type in 2019
Figure 61. Global Clinical Next-Generation Sequencing Market Share Forecast by Type (2021-2025)
Figure 62. Global Targeted Sequencing Revenue Growth Rate (2015-2020)
Figure 63. Global Exome Sequencing Revenue Growth Rate (2015-2020)
Figure 64. Global Others Revenue Growth Rate (2015-2020)
Figure 65. Global Clinical Next-Generation Sequencing Revenue Share by Application (2015-2020)
Figure 66. Global Clinical Next-Generation Sequencing Revenue Share by Application in 2019
Figure 67. Global Clinical Next-Generation Sequencing Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Biopharma Companies Revenue Growth Rate (2015-2020)
Figure 70. Global Academic and Research Organizations Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Clinical Next-Generation Sequencing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Clinical Next-Generation Sequencing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Clinical Next-Generation Sequencing Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
Figure 76. Europe Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
Figure 78. South America Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Clinical Next-Generation Sequencing Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
次世代シークエンシング (NGS) 用ライブラリー調整・ターゲットエンリッチメントの世界市場 2020年 Market Overview The global Library Preparation and Target Enrichment for Next Generation Sequencing Product market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 202…- 次世代シーケンス（NGS）サンプル前処理の世界市場 2020年 Market Overview The global Next Generation Sequencing (NGS) Sample Preparation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- 次世代シーケンス（NGS）データ分析器の世界市場 2020年 Market Overview The global Next Generation Sequencing (NGS) Data Analysis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.4% in the forecast period of 2020 to 2025 and will expected to reach USD 749.4 million by 2025, from USD 504.1 million in …
- 次世代シーケンシング用サンプル調製製品の世界市場 2020年 Market Overview The global Sample Preparation Products for Next Generation Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million…
- RNA次世代シーケンシング（NGS）の世界市場 2020年 Market Overview The global RNA Next-Generation Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The RNA Next-Gener…